Amy Krie

2.9k total citations · 1 hit paper
10 papers, 527 citations indexed

About

Amy Krie is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Amy Krie has authored 10 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Amy Krie's work include Cancer Genomics and Diagnostics (5 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Cancer Treatment Studies (4 papers). Amy Krie is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Cancer Treatment Studies (4 papers). Amy Krie collaborates with scholars based in United States, Netherlands and India. Amy Krie's co-authors include Casey Williams, Brian Leyland‐Jones, Ryosuke Okamura, Jeffrey S. Ross, Razelle Kurzrock, J. Jack Lee, Scott M. Lippman, Pradip De, Shumei Kato and Jason K. Sicklick and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Amy Krie

9 papers receiving 517 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

2019 429 citations Jason K. Sicklick, Shumei Kato et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Krie United States	5	268	257	172	172	80	10	527
Eoghan Ruadh Malone Canada	5	303 1.1×	203 0.8×	265 1.5×	158 0.9×	80 1.0×	20	605
Pam K. Mangat United States	12	322 1.2×	468 1.8×	140 0.8×	273 1.6×	99 1.2×	47	644
Leanne G. Ahronian United States	9	226 0.8×	290 1.1×	198 1.2×	174 1.0×	131 1.6×	18	524
V. Guillem Porta Spain	9	196 0.7×	474 1.8×	251 1.5×	116 0.7×	62 0.8×	16	647
Pietro De Placido Italy	13	225 0.8×	488 1.9×	245 1.4×	396 2.3×	48 0.6×	53	816
Karen A. Cadoo United States	19	162 0.6×	365 1.4×	241 1.4×	211 1.2×	106 1.3×	74	868
Daphne van der Velden Netherlands	9	322 1.2×	701 2.7×	314 1.8×	139 0.8×	62 0.8×	20	955
Budhi Singh Yadav India	13	272 1.0×	240 0.9×	133 0.8×	146 0.8×	125 1.6×	85	666
Andrew Elliott United States	10	89 0.3×	260 1.0×	191 1.1×	146 0.8×	64 0.8×	99	483
Todd Riehl United States	13	185 0.7×	431 1.7×	288 1.7×	284 1.7×	157 2.0×	28	831

Countries citing papers authored by Amy Krie

Since Specialization

Citations

This map shows the geographic impact of Amy Krie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Krie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Krie more than expected).

Fields of papers citing papers by Amy Krie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Krie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Krie. The network helps show where Amy Krie may publish in the future.

Co-authorship network of co-authors of Amy Krie

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Krie. A scholar is included among the top collaborators of Amy Krie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Krie. Amy Krie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Finnicum, Casey T., Amy Krie, Kenneth H. Cowan, et al.. (2024). Breast Cancer Polygenic Risk Score Validation and Effects of Variable Imputation. Cancers. 16(8). 1578–1578.

2.

Sicklick, Jason K., Shumei Kato, Ryosuke Okamura, et al.. (2021). Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study. Genome Medicine. 13(1). 155–155. 62 indexed citations

3.

Xu, Bing, Christel M. Davis, Jason L. Petersen, et al.. (2020). Case report: 16-yr life history and genomic evolution of an ER⁺ HER2⁻ breast cancer. Molecular Case Studies. 6(6). a005629–a005629. 2 indexed citations

4.

Williams, Casey, Kirstin Williams, Amy Krie, et al.. (2020). Results of a phase Ib trial evaluating the safety and clinical activity of sapanisertib (TAK 228) in combination with serabelisib (TAK 117) and paclitaxel in patients with advanced ovarian, endometrial, or breast cancer.. Journal of Clinical Oncology. 38(15_suppl). 3604–3604. 9 indexed citations

5.

Sicklick, Jason K., Shumei Kato, Ryosuke Okamura, et al.. (2019). Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study. Nature Medicine. 25(5). 744–750. 429 indexed citations breakdown →

6.

Maxwell, Jessica, Elizabeth Lyden, Amy Krie, et al.. (2019). The impact of the affordable care act on breast cancer care in the USA: A multi‐institutional analysis. The Breast Journal. 25(5). 948–952. 2 indexed citations

7.

Xu, Bing, et al.. (2017). Utilizing Tumor and Plasma Liquid Biopsy in Treatment Decision Making for an Estrogen Receptor-Positive Advanced Breast Cancer Patient. Cureus. 9(6). e1408–e1408. 14 indexed citations

8.

Dey, Nandini, Amy Krie, Kirstin Williams, et al.. (2017). Down’s Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship. International Journal of Molecular Sciences. 18(6). 1218–1218. 4 indexed citations

9.

Abramovitz, Mark, et al.. (2016). Identifying biomarkers to select patients with early breast cancer suitable for extended adjuvant endocrine therapy. Current Opinion in Oncology. 28(6). 461–468. 4 indexed citations

10.

De, Pradip, Casey Williams, Amy Krie, et al.. (2016). Abstract 4591: Estrogen receptor-positive breast cancer: from genomic landscape to treatment approach. Cancer Research. 76(14_Supplement). 4591–4591. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact